08:00 , Nov 7, 2011 |  BC Week In Review  |  Financial News

PathoGenetiX financial update

PathoGenetiX raised $7.5 million in the second close of a series B round, bringing the total raised in the round to $11.5 million. New investor Ascension Health Ventures joined existing investors Excel Venture Management; CB...
07:00 , Aug 8, 2011 |  BC Week In Review  |  Financial News

PathoGenetiX completes venture financing

PathoGenetiX Inc. , Woburn, Mass.   Business: Supply/Service, Genomics   Date completed: 8/1/11   Type: Venture financing   Raised: $4 million   Investors: Excel Venture Management; CB Health Ventures; HealthCare Ventures; existing investors   Note:...
08:00 , Nov 16, 2009 |  BioCentury  |  Finance

Ebb & Flow

Although the terms of the acquisition of BioTrove Inc. by Life Technologies Corp. (NASDAQ:LIFE) haven't been undisclosed, the transaction could result in a more than 10X return over the next 12 months, according to investor...
07:00 , Apr 7, 2008 |  BioCentury  |  Finance

Ebb & Flow

For small companies with constrained options in the current financing environment, alternative approaches tied to royalty or revenue interests continue to be the order of the day. Last week, a trio of alternative vehicles went...
00:47 , Oct 13, 2006 |  BC Extra  |  Financial News

Morphotek raises $40 million

Antibody company Morphotek (Exton, Penn.) raised $40 million in a series D round led by Investor Growth Capital. New investors MDS Capital and Hunt BioVentures were joined by existing investors Forward Ventures; Morgenthaler Ventures; SR...
08:00 , Jan 24, 2005 |  BioCentury  |  Finance

Ebb & Flow

It's only three weeks into January, and already there has been a healthy flow of paper. Three follow-ons, two note deals and an IPO are in the can. There's more to come, as at least...
08:00 , Jan 18, 2005 |  BC Extra  |  Financial News

GeneOhm raises $14 million

Molecular diagnostics company GeneOhm (San Diego, Calif.) raised $14 million in a second closing of its November 2004 series C round, bringing the total raised to $26 million. Investors in the second close included Kaiser...
08:00 , Feb 23, 2004 |  BioCentury  |  Finance

Ebb & Flow

Even when many companies continue to land big financing rounds, sometimes it's best to stop fishing for money. With one good deal in hand, investors in Cardion concluded that it was time to fold up...
08:00 , Feb 18, 2004 |  BC Extra  |  Financial News

Morphotek raises $26M

Antibody company Morphotek (Exton, Penn.) raised $26 million in a series C round led by Forward Ventures. Other investors included S.R. One; Morgenthaler; Rock Maple Ventures; China Development Industrial Bank; DSM Venturing; Flagship Ventures; Burrill...
08:00 , Jan 29, 2004 |  BC Extra  |  Financial News

BioTrove raises $10.9 million

Assay company BioTrove (Woburn, Mass.) raised $10.9 million in series B round. Investors included Catalyst Health and Technology Partners; CB Health Ventures; Zero Stage Capital; and BioFrontier Partners. Ben Bronstein, a managing director at ZeroStage,...